Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 60


Trends in published meta-analyses in cancer research, 2008-2013.

Qadir XV, Clyne M, Lam TK, Khoury MJ, Schully SD.

Cancer Causes Control. 2017 Jan;28(1):5-12. doi: 10.1007/s10552-016-0830-6. Epub 2016 Nov 29.


A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variation.

Hunter JE, Irving SA, Biesecker LG, Buchanan A, Jensen B, Lee K, Martin CL, Milko L, Muessig K, Niehaus AD, O'Daniel J, Piper MA, Ramos EM, Schully SD, Scott AF, Slavotinek A, Sobreira N, Strande N, Weaver M, Webber EM, Williams MS, Berg JS, Evans JP, Goddard KA.

Genet Med. 2016 Dec;18(12):1258-1268. doi: 10.1038/gim.2016.40. Epub 2016 Apr 28.


Review of the Gene-Environment Interaction Literature in Cancer: What Do We Know?

Simonds NI, Ghazarian AA, Pimentel CB, Schully SD, Ellison GL, Gillanders EM, Mechanic LE.

Genet Epidemiol. 2016 Jul;40(5):356-65. doi: 10.1002/gepi.21967. Epub 2016 Apr 7. Review.


Reproducible Research Practices and Transparency across the Biomedical Literature.

Iqbal SA, Wallach JD, Khoury MJ, Schully SD, Ioannidis JP.

PLoS Biol. 2016 Jan 4;14(1):e1002333. doi: 10.1371/journal.pbio.1002333. eCollection 2016 Jan.


What is translational genomics? An expanded research agenda for improving individual and population health.

Schully SD, Khoury MJ.

Appl Transl Genom. 2014 Dec;3(4):82-83. No abstract available.


Robustness of Next Generation Sequencing on Older Formalin-Fixed Paraffin-Embedded Tissue.

Carrick DM, Mehaffey MG, Sachs MC, Altekruse S, Camalier C, Chuaqui R, Cozen W, Das B, Hernandez BY, Lih CJ, Lynch CF, Makhlouf H, McGregor P, McShane LM, Phillips Rohan J, Walsh WD, Williams PM, Gillanders EM, Mechanic LE, Schully SD.

PLoS One. 2015 Jul 29;10(7):e0127353. doi: 10.1371/journal.pone.0127353. eCollection 2015.


ClinGen--the Clinical Genome Resource.

Rehm HL, Berg JS, Brooks LD, Bustamante CD, Evans JP, Landrum MJ, Ledbetter DH, Maglott DR, Martin CL, Nussbaum RL, Plon SE, Ramos EM, Sherry ST, Watson MS; ClinGen.

N Engl J Med. 2015 Jun 4;372(23):2235-42. doi: 10.1056/NEJMsr1406261. Epub 2015 May 27.


Evolution of the "drivers" of translational cancer epidemiology: analysis of funded grants and the literature.

Lam TK, Chang CQ, Rogers SD, Khoury MJ, Schully SD.

Am J Epidemiol. 2015 Apr 1;181(7):451-8. doi: 10.1093/aje/kwu479. Epub 2015 Mar 11. Review.


Lam et al. respond to "Driving for further evolution".

Lam TK, Chang CQ, Rogers SD, Khoury MJ, Schully SD.

Am J Epidemiol. 2015 Apr 1;181(7):463. doi: 10.1093/aje/kwu478. Epub 2015 Mar 11. No abstract available.


The authors reply.

Spitz MR, Lam TK, Schully SD, Khoury MJ.

Am J Epidemiol. 2015 Mar 1;181(5):361. doi: 10.1093/aje/kwv019. Epub 2015 Feb 18. No abstract available.


Leveraging biospecimen resources for discovery or validation of markers for early cancer detection.

Schully SD, Carrick DM, Mechanic LE, Srivastava S, Anderson GL, Baron JA, Berg CD, Cullen J, Diamandis EP, Doria-Rose VP, Goddard KA, Hankinson SE, Kushi LH, Larson EB, McShane LM, Schilsky RL, Shak S, Skates SJ, Urban N, Kramer BS, Khoury MJ, Ransohoff DF.

J Natl Cancer Inst. 2015 Feb 16;107(4). pii: djv012. doi: 10.1093/jnci/djv012. Print 2015 Apr.


SEER cancer registry biospecimen research: yesterday and tomorrow.

Altekruse SF, Rosenfeld GE, Carrick DM, Pressman EJ, Schully SD, Mechanic LE, Cronin KA, Hernandez BY, Lynch CF, Cozen W, Khoury MJ, Penberthy LT.

Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2681-7. doi: 10.1158/1055-9965.EPI-14-0490. Review.


Prevalence and correlates of receiving and sharing high-penetrance cancer genetic test results: findings from the Health Information National Trends Survey.

Taber JM, Chang CQ, Lam TK, Gillanders EM, Hamilton JG, Schully SD.

Public Health Genomics. 2015;18(2):67-77. doi: 10.1159/000368745.


The Cancer Genomics and Epidemiology Navigator: An NCI online tool to enhance cancer epidemiology research.

Schully SD, Rogers SD, Lam TK, Chang CQ, Clyne M, Cyr J, Watson D, Khoury MJ.

Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2610-1. doi: 10.1158/1055-9965.EPI-14-0902. No abstract available.


An overview of recommendations and translational milestones for genomic tests in cancer.

Chang CQ, Tingle SR, Filipski KK, Khoury MJ, Lam TK, Schully SD, Ioannidis JP.

Genet Med. 2015 Jun;17(6):431-40. doi: 10.1038/gim.2014.133. Epub 2014 Oct 23. Review.


The next generation of large-scale epidemiologic research: implications for training cancer epidemiologists.

Spitz MR, Lam TK, Schully SD, Khoury MJ.

Am J Epidemiol. 2014 Nov 15;180(10):964-7. doi: 10.1093/aje/kwu256. Epub 2014 Sep 18. Review.


The use of biospecimens in population-based research: a review of the National Cancer Institute's Division of Cancer Control and Population Sciences grant portfolio.

Carrick DM, Mette E, Hoyle B, Rogers SD, Gillanders EM, Schully SD, Mechanic LE.

Biopreserv Biobank. 2014 Aug;12(4):240-5. doi: 10.1089/bio.2014.0009. Review.


Evidence synthesis and guideline development in genomic medicine: current status and future prospects.

Schully SD, Lam TK, Dotson WD, Chang CQ, Aronson N, Birkeland ML, Brewster SJ, Boccia S, Buchanan AH, Calonge N, Calzone K, Djulbegovic B, Goddard KA, Klein RD, Klein TE, Lau J, Long R, Lyman GH, Morgan RL, Palmer CG, Relling MV, Rubinstein WS, Swen JJ, Terry SF, Williams MS, Khoury MJ.

Genet Med. 2015 Jan;17(1):63-7. doi: 10.1038/gim.2014.69. Epub 2014 Jun 19.


Multi-marker Solid Tumor Panels Using Next-generation Sequencing to Direct Molecularly Targeted Therapies.

Marrone M, Filipski KK, Gillanders EM, Schully SD, Freedman AN.

PLoS Curr. 2014 May 27;6. pii: ecurrents.eogt.aa5415d435fc886145bd7137a280a971. doi: 10.1371/currents.eogt.aa5415d435fc886145bd7137a280a971.


Collaborative biomedicine in the age of big data: the case of cancer.

Shaikh AR, Butte AJ, Schully SD, Dalton WS, Khoury MJ, Hesse BW.

J Med Internet Res. 2014 Apr 7;16(4):e101. doi: 10.2196/jmir.2496.

Supplemental Content

Loading ...
Support Center